About Digital Artefacts
Digital Artefacts is a Healthcare company based in Iowa City (United States) founded in 1999, and was acquired by Clinical Ink in November 2021. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Medidata, Verily and IQVIA; 2 of its 3 listed competitors have raised funding.
Company details
Provider of the clinical trial management platform. The platform offers end-to-end clinical trial management solutions such as patient recruitment management, patient consent and study management, study design services in various functionalities such as cognitive, movement, autoimmune, oncology, and much more. Also, it offers tools for patient engagement management, collection of participant data, cognitive testing, and patient clinical data security management.
- Headquarters Iowa City, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website digitalartefacts.com
- Social LinkedIn X
- Acquired by Clinical Ink (Nov 2021)
- Latest Funding Round$173.88K (USD), Grant
Aug 2015
- InvestorsClinical Ink
& 1 more
- Acquired byClinical Ink
(Nov 2021)
Funding Insights of Digital Artefacts
- Total Rounds 2
- Last Round Grant β $173,877
- First Round $1.3M
(Apr 2013)
- Investors Count 1
All 2 funding rounds of Digital Artefacts with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Digital Artefacts
Digital Artefacts has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Clinical Ink and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Paperless eSource and patient engagement solutions for clinical trials | 2006 | clinicalink.com | Winston-salem, United States |
Investor details for Digital Artefacts
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Digital Artefacts
4 dated milestones of Digital Artefacts across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Digital Artefacts is founded.
- Funding First funding round of $1.3M.
- Funding Latest funding round, Grant, of $174K.
- Exit Acquired by Clinical Ink.
Competitors of Digital Artefacts
Digital Artefacts has 3 listed competitors in our database, 2 of them funded. They include Medidata, Verily and IQVIA.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medidata.com | 1999 | New York, United States | $41.5M | 1,677 | Medidata is recognized as a leading provider of SaaS solutions for clinical research. | |
| verily.com | 2015 | Dallas, United States | $2.5B | AI-based solutions for health management are provided. | ||
| iqvia.com | 1982 | Durham, United States | 88,000 | Clinical research and commercialization solutions are provided for healthcare. |
Detailed competitors of Digital Artefacts
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Digital Artefacts (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Digital Artefacts
Complete news archive for Digital Artefacts
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Digital Artefacts
Digital Artefacts was founded in 1999 and raised its 1st funding round 14 years after it was founded.
Digital Artefacts is headquartered in Iowa City, United States. It is registered at Iowa City, Iowa, United States.
Provider of the clinical trial management platform. The platform offers end-to-end clinical trial management solutions such as patient recruitment management, patient consent and study management, study design services in various functionalities such as cognitive, movement, autoimmune, oncology, and much more. Also, it offers tools for patient engagement management, collection of participant data, cognitive testing, and patient clinical data security management.
Digital Artefacts has 2 investors. Key investors include Clinical Ink, and HHS.
Yes. Digital Artefacts was acquired by Clinical Ink in November 2021.

